SQUAWK/NEWS
Menu
Live News EQUITY L impact

Alaunos Therapeutics 8K filing

Alaunos Therapeutics files 8K with SEC, disclosing other events and financial statements. Filing size is 24 MB.

ALNS

Filed: 2026-05-26 AccNo: 0001193125-26-238237 Size: 24 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits